WallStSmart
STTK

Shattuck Labs Inc

NASDAQ: STTK · HEALTHCARE · BIOTECHNOLOGY

$7.15
+0.85% today

Updated 2026-04-30

Market cap
$583.49M
P/E ratio
P/S ratio
583.49x
EPS (TTM)
$-0.70
Dividend yield
52W range
$1 – $8
Volume
0.6M

Shattuck Labs Inc (STTK) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$22.44M$9.89M$9.93M$30.02M$652000.00$1.66M$5.72M$1.00M
Revenue growth (YoY)-55.9%+0.5%+202.2%-97.8%+154.1%+245.3%-82.5%
Cost of revenue$24.81M$29.22M$37.48M$1.38M$3.38M$4.04M$3.83M$3.69M
Gross profit$-2.37M$-19.33M$9.93M$28.64M$652000.00$-2.38M$5.72M$-2.69M
Gross margin-10.5%-195.5%100.0%95.4%100.0%-143.9%100.0%-268.8%
R&D$24.81M$29.22M$37.48M$56.56M$82.90M$74.31M$67.21M$35.27M
SG&A$3.78M$5.74M$9.38M$18.72M$21.08M$19.30M$19.08M$17.23M
Operating income$-6.15M$-25.07M$-36.93M$-45.27M$-103.33M$-91.96M$-80.57M$-51.51M
Operating margin-27.4%-253.5%-371.8%-150.8%-15848.0%-5549.6%-1408.3%-5150.8%
EBITDA$-4.50M$-24.53M$-36.31M$-43.89M$-100.26M$-87.92M$-76.74M$-47.84M
EBITDA margin-20.1%-248.1%-365.5%-146.2%-15376.7%-5305.7%-1341.3%-4784.4%
EBIT$-4.76M$-25.07M$-36.93M$-45.27M$-103.33M$-91.96M$-80.57M$-51.53M
Interest expense$2.63M$0.00$0.00$1.38M$3.07M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-7.39M$-23.98M$-35.44M$-44.97M$-100.56M$-87.30M$-75.41M$-48.81M
Net income growth (YoY)-224.6%-47.8%-26.9%-123.6%+13.2%+13.6%+35.3%
Profit margin-32.9%-242.6%-356.7%-149.8%-15423.5%-5268.4%-1318.1%-4880.9%